Put a ring on it: application of small aliphatic rings in medicinal chemistry

MR Bauer, P Di Fruscia, SCC Lucas… - RSC Medicinal …, 2021 - pubs.rsc.org
Aliphatic three-and four-membered rings including cyclopropanes, cyclobutanes, oxetanes,
azetidines and bicyclo [1.1. 1] pentanes have been increasingly exploited in medicinal …

Discovery of LOU064 (Remibrutinib), a potent and highly selective covalent inhibitor of Bruton's tyrosine kinase

D Angst, F Gessier, P Janser, A Vulpetti… - Journal of Medicinal …, 2020 - ACS Publications
Bruton's tyrosine kinase (BTK), a cytoplasmic tyrosine kinase, plays a central role in
immunity and is considered an attractive target for treating autoimmune diseases. The use of …

Challenges for the development of mutant isocitrate dehydrogenases 1 inhibitors to treat glioma

QX Wang, PY Zhang, QQ Li, ZJ Tong, JZ Wu… - European Journal of …, 2023 - Elsevier
Glioma is one of the most common types of brain tumors, and its high recurrence and
mortality rates threaten human health. In 2008, the frequent isocitrate dehydrogenase 1 …

Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12C

Y Shin, JW Jeong, RP Wurz, P Achanta… - ACS medicinal …, 2019 - ACS Publications
KRAS regulates many cellular processes including proliferation, survival, and differentiation.
Point mutants of KRAS have long been known to be molecular drivers of cancer. KRAS p …

Systematic Study of the Glutathione Reactivity of N-Phenylacrylamides: 2. Effects of Acrylamide Substitution

A Birkholz, DJ Kopecky, LP Volak… - Journal of Medicinal …, 2020 - ACS Publications
A comprehensive understanding of structure–reactivity relationships is critical to the design
and optimization of cysteine-targeted covalent inhibitors. Herein, we report glutathione …

Azetidine and piperidine carbamates as efficient, covalent inhibitors of monoacylglycerol lipase

CR Butler, EM Beck, A Harris, Z Huang… - Journal of Medicinal …, 2017 - ACS Publications
Monoacylglycerol lipase (MAGL) is the main enzyme responsible for degradation of the
endocannabinoid 2-arachidonoylglycerol (2-AG) in the CNS. MAGL catalyzes the …

Discovery and biological evaluation of 1-{2, 7-diazaspiro [3.5] nonan-2-yl} prop-2-en-1-one derivatives as covalent inhibitors of KRAS G12C with favorable metabolic …

T Imaizumi, M Akaiwa, T Abe, T Nigawara… - Bioorganic & Medicinal …, 2022 - Elsevier
RAS protein plays a key role in cellular proliferation and differentiation. RAS gene mutation
is a known driver of oncogenic alternation in human cancer. RAS inhibition is an effective …

Regio-and stereospecific synthesis of oridonin D-ring aziridinated analogues for the treatment of triple-negative breast cancer via mediated irreversible covalent …

Y Ding, D Li, C Ding, P Wang, Z Liu… - Journal of medicinal …, 2018 - ACS Publications
Covalent drug discovery has undergone a resurgence in recent years due to comprehensive
optimization of the structure–activity relationship (SAR) and the structure–reactivity …

Inhibitors of mutant isocitrate dehydrogenases 1 and 2 (mIDH1/2): an update and perspective

T Ma, F Zou, S Pusch, Y Xu… - Journal of Medicinal …, 2018 - ACS Publications
Isocitrate dehydrogenases 1 and 2 (IDH1/2) are homodimeric enzymes that catalyze the
conversion of isocitrate to α-ketoglutarate (α-KG) in the tricarboxylic acid cycle. However …

Targeted covalent inhibition of telomerase

RC Betori, Y Liu, RK Mishra, SB Cohen… - ACS chemical …, 2020 - ACS Publications
Telomerase is a ribonuceloprotein complex responsible for maintaining telomeres and
protecting chromosomal integrity. The human telomerase reverse transcriptase (hTERT) is …